Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 9078923 was granted and assigned to Glenmark Pharmaceuticals on July, 2015 by the United States Patent and Trademark Office. | 9078923 | July 14, 2015 | |||||||
Patent 7414143 was granted and assigned to Glenmark Pharmaceuticals on August, 2008 by the United States Patent and Trademark Office. | 7414143 | August 19, 2008 | |||||||
Patent 9518048 was granted and assigned to Glenmark Pharmaceuticals on December, 2016 by the United States Patent and Trademark Office. | 9518048 | December 13, 2016 | |||||||
Patent 7230002 was granted and assigned to Glenmark Pharmaceuticals on June, 2007 by the United States Patent and Trademark Office. | 7230002 | June 12, 2007 | |||||||
Patent 7238725 was granted and assigned to Glenmark Pharmaceuticals on July, 2007 by the United States Patent and Trademark Office. | 7238725 | July 3, 2007 | |||||||
Patent 9670160 was granted and assigned to Glenmark Pharmaceuticals on June, 2017 by the United States Patent and Trademark Office. | 9670160 | June 6, 2017 | |||||||
Patent 7291745 was granted and assigned to Glenmark Pharmaceuticals on November, 2007 by the United States Patent and Trademark Office. | 7291745 | November 6, 2007 | |||||||
Patent 9567332 was granted and assigned to Glenmark Pharmaceuticals on February, 2017 by the United States Patent and Trademark Office. | 9567332 | February 14, 2017 | |||||||
Patent 9499475 was granted and assigned to Glenmark Pharmaceuticals on November, 2016 by the United States Patent and Trademark Office. | 9499475 | November 22, 2016 | |||||||
Patent 9695159 was granted and assigned to Glenmark Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office. | 9695159 | July 4, 2017 | |||||||
Patent 10106483 was granted and assigned to Glenmark Pharmaceuticals on October, 2018 by the United States Patent and Trademark Office. | 10106483 | October 23, 2018 | |||||||
Patent 9227958 was granted and assigned to Glenmark Pharmaceuticals on January, 2016 by the United States Patent and Trademark Office. | 9227958 | January 5, 2016 | |||||||
Patent D914095 was granted and assigned to Glenmark Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office. | D914095 | March 23, 2021 | |||||||
Patent 10138190 was granted and assigned to Glenmark Pharmaceuticals on November, 2018 by the United States Patent and Trademark Office. | 10138190 | November 27, 2018 | |||||||
Patent 7649096 was granted and assigned to Glenmark Pharmaceuticals on January, 2010 by the United States Patent and Trademark Office. | 7649096 | January 19, 2010 | |||||||
Patent 9593119 was granted and assigned to Glenmark Pharmaceuticals on March, 2017 by the United States Patent and Trademark Office. | 9593119 | March 14, 2017 | |||||||
Patent 9440927 was granted and assigned to Glenmark Pharmaceuticals on September, 2016 by the United States Patent and Trademark Office. | 9440927 | September 13, 2016 | |||||||
Patent D804015 was granted and assigned to Glenmark Pharmaceuticals on November, 2017 by the United States Patent and Trademark Office. | D804015 | November 28, 2017 | |||||||
Patent 9663505 was granted and assigned to Glenmark Pharmaceuticals on May, 2017 by the United States Patent and Trademark Office. | 9663505 | May 30, 2017 | |||||||
Patent 7312329 was granted and assigned to Glenmark Pharmaceuticals on December, 2007 by the United States Patent and Trademark Office. | 7312329 | December 25, 2007 | |||||||
Patent D797920 was granted and assigned to Glenmark Pharmaceuticals on September, 2017 by the United States Patent and Trademark Office. | D797920 | September 19, 2017 | |||||||
Patent 9776985 was granted and assigned to Glenmark Pharmaceuticals on October, 2017 by the United States Patent and Trademark Office. | 9776985 | October 3, 2017 | |||||||
Patent 8673356 was granted and assigned to Glenmark Pharmaceuticals on March, 2014 by the United States Patent and Trademark Office. | 8673356 | March 18, 2014 | |||||||
Patent 9840456 was granted and assigned to Glenmark Pharmaceuticals on December, 2017 by the United States Patent and Trademark Office. | 9840456 | December 12, 2017 | |||||||
Patent 10357622 was granted and assigned to Glenmark Pharmaceuticals on July, 2019 by the United States Patent and Trademark Office. | 10357622 | July 23, 2019 |